Effects of rosiglitazone, an agonist of the peroxisome proliferator- activated receptor γ, on intestinal damage induced by Escherichia coli lipopolysaccharide in weaned pigs

American Journal of Veterinary Research

Volumn 71, Issue 11, 2010, Pages 1331-1338

  Fan, Wei ^a   Liu, Yulan ^a   Wu, Zhifeng ^a   Hong, Yu ^a   Zhu, Huiling ^a   Hou, Yongqing ^a   Yin, Yulong ^a,b   Han, Jie ^a  

^a WUHAN POLYTECHNIC UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DIMETHYL SULFOXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; DUODENUM; ENZYME ACTIVITY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; INTESTINE VILLUS; JEJUNUM; NONHUMAN; SWINE;

ALPHA-GLUCOSIDASES; ANIMALS; DUODENUM; ESCHERICHIA COLI; EUTHANASIA; FIBRINOLYTIC AGENTS; ILEUM; INTESTINAL MUCOSA; JEJUNUM; LACTASE; LIPOPOLYSACCHARIDES; NITRIC OXIDE SYNTHASE TYPE II; PPAR GAMMA; PROLIFERATING CELL NUCLEAR ANTIGEN; SUCRASE; SWINE; THIAZOLIDINEDIONES;

ANIMALIA; ESCHERICHIA COLI; SUIDAE;

EID: 78149401439     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.11.1331     Document Type: Article

References (42)

1. Yi GF, Carroll JA, Allee GL, et al. Effect of glutamine and spray-dried plasma on growth performance, small intestinal morphology, and immune responses of Escherichia coli K88+-challenged weaned pigs. J Anim Sci 2005;83:634-643.
2. Moeser AJ, vander Klok C, Ryan KA, et al. Stress signaling pathways activated by weaning mediate intestinal dysfunction in the pig. Am J Physiol Gastrointest Liver Physiol 2007;292:G173-G181.
3. Liu YL, Huang JJ, Hou YQ, et al. Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs. Br J Nutr 2008;100:552-560.
4. Moraes LA, Piqueras L, Bishop-Bailey D. Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther 2006;110:371-385.
5. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the cross-roads between lipid metabolism and inflammation. Inflamm Res 2000;49:497-505.
6. Liu YL, Lu J, Shi JX, et al. Increased expression of the peroxisome proliferator-activated receptor γ in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection. Vet Immunol Immunopathol 2008;124:82-92.
7. Nakajima A, Wada K, Miki H, et al. Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 2001;120:460-469.
8. Dubuquoy L, Rousseaux C, Thuru X, et al. PPARγ as a new therapeutic target in inflammatory bowel diseases. Gut 2006;55:1341-1349.
9. Sánchez-Hidalgo M, Martin AR, Villegas I, et al. Rosiglitazone, a PPARγ ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Eur J Pharmacol 2007;562:247-258.
10. Takagi T, Naito Y, Tomatsuri N, et al. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade. Redox Rep 2002;7:283-289.
11. Auwerx J. Nuclear receptors: I. PPAR gamma in the gastrointestinal tract: gain or pain? Am J Physiol Gastrointest Liver Physiol 2002;282:G581-G585.
12. Katayama K, Wada K, Nakajima A, et al. A novel PPAR? gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 2003;124:1315-1324.
13. Ghose R, Mulder J, von Furstenberg RJ, et al. Rosiglitazone attenuates suppression of RXR?-dependent gene expression in inflamed liver. J Hepatol 2007;46:115-123.
14. Jeon EJ, Lee SK, Park YS, et al. The effects of peroxisome proliferator-activated receptor-? agonist on a murine model of experimental allergic rhinitis. Otolaryngol Head Neck Surg 2008;139:124-130.
15. Cuzzocrea S, Pisano B, Dugo L, et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. Eur J Pharmacol 2004;483:79-93. (Pubitemid 38056607)
16. Touchette KJ, Carroll JA, Allee GL, et al. Effect of spray-dried plasma and lipopolysaccharide exposure on weaned pigs: I. Effects on the immune axis of weaned pigs. J Anim Sci 2002;80:494-501.
17. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with folin phenol reagent. J Biol Chem 1951;193:265-275.
18. Dahlqvist A. Assay of intestinal disaccharidases. Anal Biochem 1968;22:99-107.
19. Gookin JL, Marc Rhoads J, Argenzio RA. Inducible nitric oxide synthase mediates early epithelial repair of porcine ileum. Am J Physiol Gastrointest Liver Physiol 2002;283:G157-G168.
20. Wan S, Arifi AA, Chan MCW, et al. Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts. Eur J Cardiothorac Surg 2006;29:742-747.
21. Johnson RW, von Borell E. Lipopolysaccharide-induced sickness behavior in pigs is inhibited by pretreatment with indomethacin. J Anim Sci 1994;72:309-314.
22. Mercer DW, Smith GS, Cross JM, et al. Effects of lipopolysaccharide on intestinal injury: potential role of nitric oxide and lipid peroxidation. J Surg Res 1996;63:185-192.
23. Sánchez-Hidalgo M, Martin AR, Villegas I, et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochem Pharmacol 2005;69:1733-1744.
24. 2, ligands of the peroxisome proliferator- activated receptor-γ (PPARγ), reduce ischemia/reperfusion injury of the gut. Br J Pharmacol 2003;140:366-376.
25. Hampson DJ, Kidder DE. Influence of creep feeding and weaning on brush border enzyme activities in the piglet small intestine. Res Vet Sci 1986;40:24-31.
26. Wong WM, Wright NA. Cell proliferation in gastrointestinal mucosa. J Clin Pathol 1999;52:321-333.
27. Sukhotnik I, Mogilner J, Krausz MM, et al. Oral arginine reduces gut mucosal injury caused by lipopolysaccharide endotoxemia in rat. J Surg Res 2004;122:256-262.
28. Wu XQ, Wang H, Sun M, et al. Effect of endotoxemia on enterocyte apoptosis and PCNA expression in baby rats. World Chin J Digestol 2005;13:621-625. (Pubitemid 40529605)
29. Kim KY, Kim SS, Cheon HG. Differential anti-proliferative actions of peroxisome proliferator-activated receptor-γ agonists in MCF-7 breast cancer cells. Biochem Pharmacol 2006;72:530-540.
30. Cerbone A, Toaldo C, Laurora S, et al. 4-Hydroxynonenal and PPARγ ligands affect proliferation, differentiation, and apoptosis in colon cancer cells. Free Radic Biol Med 2007;42:1661-1670.
31. Sun WH, Chen GS, Qu XL, et al. Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor γ synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells. Cancer Lett 2009;275:247-255.
32. Delerive P, Fruchart JC, Staels B. Peroxisome proliferators: activated receptors in inflammation control. J Endocrinol 2001;169:453-459.
33. Michalik L, Wahli W. Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest 2006;116:598-606.
34. Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis. Gastroenterology 2003;124:1265-1276.
35. Binion DG, West GA, Ina K, et al. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology 1997;112:1895-1907.
36. Shen LJ, Lin WC, Beloussow K, et al. Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochem Pharmacol 2003;66:1945-1952.
37. García-Bueno B, Madrigal JLM, Lizasoain I, et al. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats. Biol Psychiatry 2005;57:885-894.
38. Potoka DA, Upperman JS, Zhang XR, et al. Peroxynitrite inhibits enterocyte proliferation modulates src kinase activity in vitro. Am J Physiol Gastrointest Liver Physiol 2003;285:G861-G869.
39. Han XN, Osuntokun B, Benight N, et al. Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis. Am J Pathol 2006;169:1999-2013.
40. Ferruzzi P, Ceni E, Tarocchi M, et al. Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R. J Clin Endocrinol Metab 2005;90:1332-1339.
41. 12,14-prostaglandin J2 on bleomycin-induced lung injury. Eur Respir J 2005;25:225-234.
42. Honda K, Marquillies P, Capron M, et al. Peroxisome proliferator- activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model. J Allergy Clin Immunol 2004;113:882-888.